Release Date: 13/03/17 10:04 Summary: Independent Test Results validates LWP's Proppant Technology Price Sensitive: Yes Download Document 671.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%